Skip to content

ROLE OF CERTAIN TOPICAL AYURVEDIC DRUGS IN THE MANAGEMENT OF SQUAMOUS BLEPHARITIS

A Prospective Randomized Comparative Clinical study to evaluate the efficacy of Saindhavadi Lepa and Shunthayadi Pratisarana in the management of Klinnvartama W.S.R. to Squamous Blepharitis.

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/12/016776
Enrollment
30
Registered
2018-12-24
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: H010- Blepharitis

Interventions

Intervention1: Saindhavadi Lepa: Total 15 patients in group A will be treated with Saindhavadi Lepa for 15 days. Control Intervention1: Shunthyadi Pratisarana: Total 15 patients in group B will be tre

Sponsors

National Institute of ayurveda Jaipur
Lead Sponsor
Dr Ankita Sharma
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Patients presenting with signs and symptoms of Klinnavartma (Squamous Blepharitis) described as per Ayurvedic and modern parlance.

Exclusion criteria

Exclusion criteria: 1.Patients suffering from any systemic disease such as diabetes, autoimmune diseases including systemic lupus erythematous, psoriasis, Sjogrenâ??s syndrome. 2.Patients suffering from any associated ocular diseases like Dry eye, Computer vision syndrome, ulcerative blepharitis, Allergic conjunctivitis, corneal ulcer, ectropion, entropion and Dacryocystitis. 3.Blepharitis with complications like blepharcojunctivitis, hordeolum, chalazion, trichiasis.

Design outcomes

Primary

MeasureTime frame
Change in the investigator assessment score for decrease in the Itching of eyelids, Pricking pain, Lacrimation, Burning sensation,Lid edema, Congestion, Scales on lid margins, Falling of eye lashes etc. Timepoint: 2 months 15 days

Secondary

MeasureTime frame
Any adverse event reported voluntarily ,observed or enquired. Prevention of recurrence of Klinnavartma ( Squamous Blepharitis ) Timepoint: 2 months 15 days

Countries

India

Contacts

Public ContactDr Ankita Sharma

National Institute of Ayurveda

dr.sharmaanki@gmail.com9462833789

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026